Healthcare

While Globus Medical showcases exceptional financial performance with record-breaking results and elevated guidance, company directors are simultaneously executing multi-million dollar...

Intellia Therapeutics shares are experiencing a dramatic downturn after a patient death in a pivotal clinical study triggered multiple analyst...

UnitedHealth Group's stock has delivered a stunning performance this week, mounting a powerful recovery that saw its value surge nearly...

The recent market reaction to Hims & Hers Health, Inc. presents a curious case of corporate expansion meeting investor skepticism....

After suffering one of the most significant downturns this year, UnitedHealth Group is showing tentative signs of a recovery. The...

The healthcare conglomerate Johnson & Johnson is demonstrating remarkable resilience in volatile market conditions, propelled by an outstanding earnings report...

The landscape for Walgreens has fundamentally shifted following its acquisition by private equity firm Sycamore Partners in August 2025 and...

A patient death during a critical Phase 3 study has triggered a severe downturn for gene-editing company Intellia Therapeutics. The...

The pharmaceutical giant's intensified focus on cancer research is yielding tangible results. Bristol-Myers Squibb is advancing its oncology pipeline through...

November 14, 2024, delivered a devastating blow to Hims & Hers Health investors as the company's stock value collapsed by...